Diabetes Clinical Trials in Orlando, FL

46 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus	Phase 2	Sun Pharmaceutical Industries Limited	<1 mi
Fenofibrate for Prevention of DR Worsening	Phase 3	Jaeb Center for Health Research	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	<1 mi
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting	—	Bayer	<1 mi
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)	Phase 3	Eli Lilly and Company	<1 mi
Capability Assessment for Diet and Activity (CADA) Model for Diabetes	—	University of Central Florida	<1 mi
Closed Loop and Education for Hypoglycemia Awareness Restoration	N/A	Milton S. Hershey Medical Center	<1 mi
Dynamic in Vivo PET Imaging and ex Vivo Biopsies From Skeletal Muscle and Adipose Tissue to Investigate the Effects of Exercise on Insulin Resistance and Mitochondrial Energetics in Type 2 Diabetes	N/A	AdventHealth Translational Research Institute	<1 mi
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes	N/A	Endogenex, Inc.	<1 mi
The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults	N/A	AdventHealth Translational Research Institute	<1 mi
Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency	Phase 1	Sun Pharmaceutical Industries Limited	<1 mi
Transdisciplinary Care for Young Adults With Type 1 Diabetes	N/A	Nemours Children's Clinic	<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics	—	Milton S. Hershey Medical Center	<1 mi
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)	Phase 2	Sanofi	<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms	—	Milton S. Hershey Medical Center	<1 mi
Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes	—	Nemours Children's Clinic	<1 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	<1 mi
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight	Phase 3	Eli Lilly and Company	<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)	—	AdventHealth Translational Research Institute	<1 mi
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial	N/A	Sonavex, Inc.	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis	Phase 2/3	CSL Behring	<1 mi
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease	Phase 3	Alessandro Doria	<1 mi
Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis	N/A	AdventHealth Translational Research Institute	<1 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity	Phase 3	Eli Lilly and Company	5 mi
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	5 mi
Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist	Phase 2	AstraZeneca	5 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Phase 3	Eli Lilly and Company	5 mi
Different Doses of Naronapride Vs. Placebo in Gastroparesis	Phase 2	Dr. Falk Pharma GmbH	6 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	10 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes	Phase 3	Eli Lilly and Company	10 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes	Phase 3	Novo Nordisk A/S	10 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide	Phase 2	Eli Lilly and Company	14 mi
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide	Phase 3	Novo Nordisk A/S	16 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Phase 3	Prokidney	19 mi
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes	Phase 2	Hoffmann-La Roche	24 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	24 mi
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes	Phase 3	Kailera	29 mi
A Clinical Investigation Evaluating Wound Closure with OptiPulse™ Versus SOC in the Treatment of Non-Healing DFU's	N/A	Compedica Inc	34 mi
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL	Phase 4	HealthTech Wound Care	34 mi
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers	N/A	Integra LifeSciences Corporation	36 mi
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy	Phase 2	Boehringer Ingelheim	42 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease	Phase 2	Novo Nordisk A/S	42 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)	Phase 2	Sparrow Pharmaceuticals	43 mi
A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes	Phase 3	Hoffmann-La Roche	48 mi
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin	Phase 2	Eli Lilly and Company	49 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.